Search - tctmd.com

Displaying 301 - 320 of 1163

Sort: Relevancy | Date

Presentation THT 2025

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Presenter: Stefan Anker

February 11, 2025

Presentation THT 2025

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Con

Presenter: Zachary Cox

February 11, 2025

Presentation THT 2025

Pro

Presenter: Wendy McCallum

February 11, 2025

Presentation THT 2025

Left Bundle Branch Area Pacing: Implications for Long Term LV Function in Heart Failure

Presenter: Brett Atwater

February 11, 2025

Presentation THT 2025

Advances in Defibrillation for Patients With Heart Failure: Extravascular ICD and Beyond

Presenter: Sunil Kapur

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Electrophysiological Characteristics and Clinical Outcomes of Truncal, Fascicular and Left Ventricular Septal Pacing in Patients Receiving Left Bundle Branch Area Pacing

Presenter: Shunmuga Ponnusamy

February 11, 2025

Presentation THT 2025

Is There a Difference in the Benefits of AF Ablation in HFrEF vs HFpEF?

Presenter: Andrea Russo

February 11, 2025

Presentation THT 2025

Left Atrial Appendage Closure: Should We Give Heart Failure Patients With AF the OPTION

Presenter: NULL

February 11, 2025

Presentation THT 2025

Future Cardia

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Microtech

Presenter: Yoram Richter

February 11, 2025

Presentation THT 2025

Vectorious: LAP-Guided Patient Self-Management

Presenter: William Abraham

February 11, 2025

Presentation THT 2025

Fire One

Presenter: Kunjan Bhatt

February 11, 2025

Presentation THT 2025

Gene Therapy for HCM: Is a Cure Coming?

Presenter: Nosheen Reza

February 11, 2025

Presentation THT 2025

Are We Ever Going to Have New Medical Therapy Options for Nonobstructive HCM?

Presenter: Anjali Owens

February 11, 2025

Presentation THT 2025

Prospective Validation of Machine Learning in Risk Stratification of Patients Treated for Cardiogenic Shock

Presenter: Shuojohn Li

February 11, 2025

Presentation THT 2025

Natriuretic Response to Furosemide: The Role of Hypochloremia and Chloride Supplementation: A Sub Analysis of the SALT-HF Trial

Presenter: Julio Núñez Villota

February 11, 2025

Presentation THT 2025

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

Presenter: Martin Maron

February 11, 2025

Presentation THT 2025

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Presenter: Hiroo Takayama

February 11, 2025

Advertisement

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Con

Pro

Left Bundle Branch Area Pacing: Implications for Long Term LV Function in Heart Failure

Advances in Defibrillation for Patients With Heart Failure: Extravascular ICD and Beyond

Special Late-Breaking Clinical Science Abstract: Electrophysiological Characteristics and Clinical Outcomes of Truncal, Fascicular and Left Ventricular Septal Pacing in Patients Receiving Left Bundle Branch Area Pacing

Is There a Difference in the Benefits of AF Ablation in HFrEF vs HFpEF?

Left Atrial Appendage Closure: Should We Give Heart Failure Patients With AF the OPTION

Future Cardia

Microtech

Vectorious: LAP-Guided Patient Self-Management

Fire One

Gene Therapy for HCM: Is a Cure Coming?

Are We Ever Going to Have New Medical Therapy Options for Nonobstructive HCM?

Prospective Validation of Machine Learning in Risk Stratification of Patients Treated for Cardiogenic Shock

Natriuretic Response to Furosemide: The Role of Hypochloremia and Chloride Supplementation: A Sub Analysis of the SALT-HF Trial

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content